1-4 of 4
Thomas Kerkau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease

Free
Niklas Beyersdorf, Xin Ding, Thomas Hünig, Thomas Kerkau
Journal: Blood
Blood (2009) 114 (20): 4575–4582.
https://doi.org/10.1182/blood-2009-04-218248
Published: 2009
Includes: Supplemental data
Journal Articles

Protection from graft-versus-host disease with a novel B7 binding site–specific mouse anti–mouse CD28 monoclonal antibody

Free
Niklas Beyersdorf, Xin Ding, Gregor Blank, Kevin M. Dennehy, Thomas Kerkau, Thomas Hünig
Journal: Blood
Blood (2008) 112 (10): 4328–4336.
https://doi.org/10.1182/blood-2008-03-146662
Published: 2008
Includes: Supplemental data
Journal Articles

Superagonistic Anti-CD28 Antibody TGN1412 as a Potential Immunotherapeutic for the Treatment of B Cell Chronic Lymphocytic Leukemia.

Free
Chia-Huey Lin, PhD, Thomas Kerkau, MD, Christine Guntermann, PhD, Martin Trischler, PhD, Niklas Beyersdorf, MD, Yvonne Scheuring, Hans-Peter Tony, MD, Christian Kneitz, MD, Martin Wilhelm, MD, Peter Mueller, PhD, Thomas Huenig, PhD, Thomas Hanke, PhD
Journal: Blood
Blood (2004) 104 (11): 2519.
https://doi.org/10.1182/blood.V104.11.2519.2519
Published: 2004
Journal Articles

Rapid recovery from T lymphopenia by CD28 superagonist therapy

Free
Karin Elflein, Marta Rodriguez-Palmero, Thomas Kerkau, Thomas Hünig
Journal: Blood
Blood (2003) 102 (5): 1764–1770.
https://doi.org/10.1182/blood-2002-11-3586
Published: 2003